Insmed Incorporated INSM
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.52B | 1.14B | 819.56M | 606.42M | 447.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.52B | 1.14B | 819.56M | 606.42M | 447.02M |
| Cost of Revenue | 237.07M | 188.22M | 149.08M | 122.94M | 104.87M |
| Gross Profit | 1.28B | 949.42M | 670.48M | 483.49M | 342.15M |
| SG&A Expenses | 960.24M | 893.59M | 800.88M | 701.17M | 631.20M |
| Depreciation & Amortization | 11.15M | 7.64M | 6.82M | 6.00M | 5.33M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.15B | 1.95B | 1.78B | 1.60B | 1.44B |
| Operating Income | -633.13M | -812.65M | -965.22M | -994.78M | -990.28M |
| Income Before Tax | -598.06M | -869.11M | -1.18B | -1.27B | -1.18B |
| Income Tax Expenses | 7.55M | 6.21M | 5.58M | 5.03M | 4.74M |
| Earnings from Continuing Operations | -605.61 | -875.31 | -1.18K | -1.28K | -1.18K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -605.61M | -875.31M | -1.18B | -1.28B | -1.18B |
| EBIT | -633.13M | -812.65M | -965.22M | -994.78M | -990.28M |
| EBITDA | -611.03M | -794.96M | -949.04M | -980.46M | -978.79M |
| EPS Basic | -2.82 | -4.11 | -5.74 | -6.40 | -6.18 |
| Normalized Basic EPS | -1.93 | -2.46 | -3.00 | -3.21 | -3.33 |
| EPS Diluted | -2.82 | -4.11 | -5.75 | -6.41 | -6.19 |
| Normalized Diluted EPS | -1.93 | -2.46 | -3.00 | -3.21 | -3.33 |
| Average Basic Shares Outstanding | 865.25M | 858.22M | 830.17M | 795.56M | 760.94M |
| Average Diluted Shares Outstanding | 865.25M | 858.22M | 830.17M | 795.56M | 760.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |